User login
- /content/mogamulizumab-prolongs-pfs-ctcl
- /hematology-oncology/article/184781/lymphoma-plasma-cell-disorders/mogamulizumab-prolongs-pfs-ctcl
- /hematologytimes/article/184781/lymphoma-plasma-cell-disorders/mogamulizumab-prolongs-pfs-ctcl
- /b-cell-lymphoma-icymi/article/184781/lymphoma-plasma-cell-disorders/mogamulizumab-prolongs-pfs-ctcl